Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
JNJ · against 596 other Healthcare companies listed in US-listed
Ranked #325 of 597 · scores higher than 46% of peers · safety percentile 38
Bars: peers in each 10-point band of the safety percentile (higher = safer; 67+ earns the lower-risk grade)55 peers with a safety percentile of 30–39, including JNJ · Click a bar to see the companies
A mix: stronger beta, but weaker current ratio and debt / equity than most Healthcare peers.
Risk is relative to the sector, not a bankruptcy probability. Banks and brokers carry high leverage by design, and share buybacks can shrink equity and current assets, which raises debt/equity on paper.
| Metric | JNJ | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Debt / equityLower is better · 523 reported | 0.58× | 0.23× | 34% | 33% | |
| BetaLower is better · 555 reported | 0.23 | 0.94 | 89% | 33% | |
| Current ratioHigher is better · 601 reported | 1.09× | 3.91× | 8% | 33% |
| Rank | Company | Market cap | Safety | Overall |
|---|---|---|---|---|
| 1 | 510M USD | 100 | ||
| 1 | 4.6B USD | 100 | 54 | |
| 1 | 5.3B USD | 100 | 45 | |
| 4 | 252M USD | 100 | 52 | |
| 5 | 1.9B USD | 100 | 44 | |
| 321 | 4.3B USD | 38 | 54 | |
| 322 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score
| 896M USD |
| 38 |
| 78 |
| 323 | 34M USD | 38 | 24 |
| 324 | 105M USD | 38 | 63 |
| 325 | 622.8B USD | 38 | 59 |
| 326 | 1.6B USD | 37 | 33 |
| 327 | 6.8B USD | 37 | 65 |
| 328 | 1.2B USD | 37 | 18 |
| 329 | 1.1B USD | 37 |